Otros idiomas Kaken Pharmaceutical Co., Ltd.

Acciones

4521

JP3207000005

Mercado cerrado - Japan Exchange Otros sitios de cotización 08:00:00 02/05/2024			Varia. Cinco días.	Varia. 1 de enero.
3.478 ^JPY	+0,03 %		+2,08 %	+3,67 %

2023	Kaken Pharmaceutical Co. Ltd. proporciona una previsión financiera consolidada para el año fiscal que finaliza el 31 de marzo de 2024	CI
2023	El beneficio atribuible de Kaken Pharmaceutical cae un 13,7% en el primer trimestre fiscal debido al aumento de los gastos	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Kaken Pharmaceutical Co., Ltd. Declares Dividend for the Second Quarter of Fiscal Ending March 2024, Payable on November 30, 2023; Provides Dividend Guidance for the Full Year Ending March 31, 2024	14/11
Kaken Pharmaceutical Co., Ltd. Provides Consolidated Financial Forecast for Fiscal Year Ending March 31, 2024	14/11
Kaken Pharmaceutical : Presentation material for meeting	09/11
Kaken Pharmaceutical : Reference Data of Financial Statements for the 2Q of Fiscal 2023	08/11
Kaken Pharmaceutical : Corporate Report 2023	01/11
Kaken Pharmaceutical Co., Ltd.(TSE:4521) dropped from FTSE All-World Index	18/09/23
Kaken Pharmaceutical’s Attributable Profit Drops 13.7% in Fiscal Q1 due to Higher Expenses	18/08/23
Kaken Pharmaceutical Co., Ltd. Provides Dividend Forecast for Second Quarter of 2024 and Fiscal Year Ending March 31, 2024	17/08/23
Kaken Pharmaceutical Co., Ltd. Provides Consolidated Financial Forecast for Fiscal Year Ending March 31, 2024	17/08/23
Kaken Pharmaceutical : Reference Data of Consolidated Financial Results for 1st Quarter of Fiscal 2023	04/08/23
MediWound Announces Commercial Launch of NexoBrid in Japan	02/08/23
MediWound Partner Launches NexoBrid in Japan	01/08/23
Botanix Pharmaceuticals Partner Secures Sublicense, Distribution Deal in Korea	05/06/23
Numab Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of NM26 Program	16/05/23
Kaken Pharmaceutical : Presentation material for meeting	11/05/23
Kaken Pharmaceutical : Reference Data of Financial Statements Fiscal 2022	10/05/23
Kaken Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	10/05/23
Kaken Pharmaceutical : Consolidated Financial Results for the Fiscal 2022	10/05/23
Kaken Pharmaceutical : Reference Data of Financial Statements for the 3Q of Fiscal 2022	03/02/23
Kaken Pharmaceutical : Consolidated Financial Results for the Third Quarter of Fiscal 2022	03/02/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Kaken Pharmaceutical Co., Ltd.

Acciones

4521

JP3207000005

Otros idiomas

Filtros